Search

Author/Creator Liebman, Howard A.

5. Life‐threatening delayed hyperhemolytic transfusion reaction in a patient with sickle cell disease: effective treatment with eculizumab followed by rituximab. Issue 10 (18th May 2015)

Authors:
Boonyasampant, Mark; Weitz, Ilene C.; Kay, Brian; Boonchalermvichian, Chaiyaporn; Liebman, Howard A.; Shulman, Ira A.
Journal:
Transfusion
Issue:
Volume 55:Issue 10(2015)
Page Start:
2398
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Low‐dose anti‐CD20 veltuzumab given intravenously or subcutaneously is active in relapsed immune thrombocytopenia: a phase I study. (6th July 2013)

Authors:
Liebman, Howard A.; Saleh, Mansoor N.; Bussel, James B.; Negrea, Ovidiu George; Horne, Heather; Wegener, William A.; Goldenberg, David M.
Journal:
British journal of haematology
Issue:
Volume 162:Number 5(2013:Sep.)
Page Start:
693
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Phase 2 study of efgartigimod, a novel FcRn antagonist, in adult patients with primary immune thrombocytopenia. Issue 2 (10th December 2019)

Authors:
Newland, Adrian C.; Sánchez‐González, Blanca; Rejtő, László; Egyed, Miklos; Romanyuk, Nataliya; Godar, Marie; Verschueren, Katrien; Gandini, Domenica; Ulrichts, Peter; Beauchamp, Jon; Dreier, Torsten; Ward, E. Sally; Michel, Marc; Liebman, Howard A.; de Haard, Hans; Leupin, Nicolas; Kuter, David J.
Journal:
American journal of hematology
Issue:
Volume 95:Issue 2(2020:Feb.)
Page Start:
178
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Prediction and prevention of thromboembolic events with enoxaparin in cancer patients with elevated tissue factor‐bearing microparticles: a randomized‐controlled phase II trial (the Microtec study). (13th December 2012)

Authors:
Zwicker, Jeffrey I.; Liebman, Howard A.; Bauer, Kenneth A.; Caughey, Thomas; Campigotto, Federico; Rosovsky, Rachel; Mantha, Simon; Kessler, Craig M.; Eneman, Jonathan; Raghavan, Vidya; Lenz, Heinz‐Joseph; Bullock, Andrea; Buchbinder, Elizabeth; Neuberg, Donna; Furie, Bruce
Journal:
British journal of haematology
Issue:
Volume 160:Number 4(2013:Feb.)
Page Start:
530
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Predictors of Venous Thromboembolism and Early Mortality in Lung Cancer: Results from a Global Prospective Study (CANTARISK). (8th November 2017)

Authors:
Kuderer, Nicole M.; Poniewierski, Marek S.; Culakova, Eva; Lyman, Gary H.; Khorana, Alok A.; Pabinger, Ingrid; Agnelli, Giancarlo; Liebman, Howard A.; Vicaut, Eric; Meyer, Guy; Shepherd, Frances A.
Journal:
Oncologist
Issue:
Volume 23:Number 2(2018)
Page Start:
247
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Tapering thrombopoietin receptor agonists in primary immune thrombocytopenia: Expert consensus based on the RAND/UCLA modified Delphi panel method. Issue 1 (8th December 2020)

Authors:
Cuker, Adam; Despotovic, Jenny M.; Grace, Rachael F.; Kruse, Caroline; Lambert, Michele P.; Liebman, Howard A.; Lyons, Roger M.; McCrae, Keith R.; Pullarkat, Vinod; Wasser, Jeffrey S.; Beenhouwer, David; Gibbs, Sarah N.; Yermilov, Irina; Broder, Michael S.
Journal:
Research and practice in thrombosis and haemostasis
Issue:
Volume 5:Issue 1(2021)
Page Start:
69
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗